PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
about
Mangiferin and Cancer: Mechanisms of Action.The wound healing, chronic fibrosis, and cancer progression triadEffects of Ranolazine on Astrocytes and Neurons in Primary CultureCancer biology in diabetes.Association between paraoxonases gene expression and oxidative stress in hepatotoxicity induced by CCl4.The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.Molecular Characterization and Expression Analysis of the Peroxisome Proliferator Activated Receptor Delta (PPARδ) Gene before and after Exercise in Horse.Diabetes and alpha lipoic Acid.A systematic analysis of human lipocalin family and its expression in esophageal carcinoma.Age-associated chronic diseases require age-old medicine: role of chronic inflammation.The insulin receptor: a new target for cancer therapy.Erythropoietin and IGF-1 signaling synchronize cell proliferation and maturation during erythropoiesisCancer and diet: How are they related?Therapeutic implications of targeting energy metabolism in breast cancer.Peroxisome proliferator-activated receptor-γ agonist troglitazone suppresses transforming growth factor-β1 signalling through miR-92b upregulation-inhibited Axl expression in human keloid fibroblasts in vitro.PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer.Insulin-like growth factor 1: common mediator of multiple enterotrophic hormones and growth factors.Comparative hepatotoxicity of 6:2 fluorotelomer carboxylic acid and 6:2 fluorotelomer sulfonic acid, two fluorinated alternatives to long-chain perfluoroalkyl acids, on adult male mice.Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway.A HIERARCHICAL BAYESIAN MODEL FOR INFERENCE OF COPY NUMBER VARIANTS AND THEIR ASSOCIATION TO GENE EXPRESSION.Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARγ-SIRT1 feedback loop.Collaborative Power of Nrf2 and PPARγ Activators against Metabolic and Drug-Induced Oxidative InjuryGranatum: a graphical single-cell RNA-Seq analysis pipeline for genomics scientists.VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin.Tolerability and pharmacokinetics of lobeglitazone, a novel peroxisome proliferator-activated receptor-γ agonist, after a single oral administration in healthy female subjects.Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis.
P2860
Q26745565-8DAB5804-9486-4A32-8F5F-7A559D2E1DE8Q27014616-63A52853-BB1E-4E80-8ADD-767D3083D8CBQ28550579-09FB9F4D-8480-4226-8E29-FE9FC85C881EQ33608038-2CA8E9B3-3DE5-4AF3-9123-C366C0726E62Q34590741-C7497DF0-2F04-4220-8155-52C4425D3AADQ34682265-DB77349C-5DCC-440D-97AC-5C59B047FBFBQ35548267-29527B30-B321-4023-A7FB-20500F81A5C3Q35564911-32864254-C719-4BF0-8EB8-4D286E2C1404Q35804193-50C3D631-9710-4CF2-AEF8-D8DFAB120670Q35923150-8FD2F879-A084-4FE7-AA68-4A9ED1D12A0CQ35972002-8516163B-F0A6-42F3-9F8D-CC87FA5CFD2BQ36424904-136E8497-EEF9-4F31-B4BC-570F975616F6Q36587800-72F7A819-7213-422C-889C-2C6DCC7E60B6Q36619161-C7A67F4A-C812-4661-A519-14FD20764BA6Q37227987-C48D0CBB-607D-4525-9154-F3BEBA656B9EQ37656960-6344C998-6778-4C9C-8961-D2BB9A61B6B3Q37699907-10E134D0-944E-4890-9449-5CC35727C260Q37975414-55C61C7B-D64D-4F68-A0D7-2C18A816168CQ39055294-6FD5DBD6-21C5-4B05-A799-403C5D949297Q39251611-8C6C0C17-C389-4BDA-820D-474C0945D6B6Q39515956-EC6B9AE9-4647-4128-8BCD-AF706A33656EQ41441045-38EA2FA0-07CD-4DB8-AB1C-64DB60CE13C6Q41449206-6F70124B-1EEA-43B5-993D-0E4B4B6856A5Q47104977-63480621-36A1-4AFF-BEBA-F78C2A7D7EA6Q50116117-8394201E-6486-4DEB-83B5-2B29C68EA473Q51141579-A766654D-4590-4A4B-BFE2-4F5162A91ACCQ52594525-0AB2F960-9146-4BBF-8B7C-05536D5ECD4D
P2860
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@ast
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@en
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@en-gb
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@nl
type
label
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@ast
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@en
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@en-gb
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@nl
altLabel
PPAR-γAgonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer
@en
prefLabel
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@ast
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@en
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@en-gb
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@nl
P2860
P3181
P356
P1433
P1476
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer
@en
P2093
R Malaguarnera
P2860
P304
P3181
P356
10.1155/2009/830501
P407
P577
2009-07-07T00:00:00Z